LEXX earnings
Lexaria Bioscience (LEXX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- LEXX reports next on Nov 25, 2026, with EPS of -0.90 expected.
- LEXX beat EPS estimates in 4 of its last 11 reports.
LEXX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Jul 13, 2026 | -1.20 | -0.90 | -33.33% | $0.00 |
| Q2 2026 | Apr 13, 2026 | -0.90 | – | – | $20.00K |
| Q1 2026 | Jan 13, 2026 | -1.05 | -1.95 | 46.15% | $0.00 |
| Q4 2025 | Nov 26, 2025 | -2.10 | -2.40 | 12.50% | $174.00K |
| Q3 2025 | Jul 14, 2025 | -3.15 | -2.25 | -40.00% | $174.00K |
| Q2 2025 | Apr 14, 2025 | -2.25 | -2.40 | 6.25% | $174.00K |
| Q1 2025 | Jan 10, 2025 | -2.40 | -1.80 | -33.33% | $183.92K |
| Q4 2024 | Nov 26, 2024 | -2.25 | – | – | $84.00K |
| Q3 2024 | Jul 12, 2024 | -1.95 | -1.50 | -30.00% | $84.00K |
| Q2 2024 | Apr 9, 2024 | -0.90 | -1.50 | 40.00% | $145.00K |
| Q1 2024 | Jan 12, 2024 | -1.95 | -1.65 | -18.18% | $151.28K |
| Q4 2023 | Nov 21, 2023 | -1.80 | – | – | $30.74K |
| Q3 2023 | Jul 14, 2023 | -5.55 | – | – | $77.71K |
| Q2 2023 | Apr 14, 2023 | -3.30 | – | – | $20.02K |
| Q1 2023 | Jan 17, 2023 | -4.50 | -0.21 | -2042.86% | $97.73K |
| Q4 2022 | Nov 25, 2022 | -3.60 | -3.15 | -14.29% | $111.15K |